Cargando…
A Systematic Review and Meta-Analysis on the Real-World Effectiveness of COVID-19 Vaccines against Infection, Symptomatic and Severe COVID-19 Disease Caused by the Omicron Variant (B.1.1.529)
Real-world data on the effectiveness of COVID-19 vaccines against the Omicron variant (B.1.1.529) is limited. This systematic review aimed to investigate the real-world effectiveness and durability of protection conferred by primary course and booster vaccines against confirmed Omicron infection, an...
Autores principales: | Mohammed, Hassen, Pham-Tran, Dan Duy, Yeoh, Zi Yi Michelle, Wang, Bing, McMillan, Mark, Andraweera, Prabha H., Marshall, Helen S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965204/ https://www.ncbi.nlm.nih.gov/pubmed/36851102 http://dx.doi.org/10.3390/vaccines11020224 |
Ejemplares similares
-
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
por: Andrews, Nick, et al.
Publicado: (2022) -
A comprehensive review on Covid-19 Omicron (B.1.1.529) variant
por: Manjunath, R, et al.
Publicado: (2022) -
SARS-CoV-2 Omicron (B.1.1.529) Variant: A Challenge with COVID-19
por: Mohseni Afshar, Zeinab, et al.
Publicado: (2023) -
Outcomes of Elderly Patients Hospitalized with the SARS-CoV-2 Omicron B.1.1.529 Variant: A Systematic Review
por: Fericean, Roxana Manuela, et al.
Publicado: (2023) -
Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance
por: Chen, Jiahui, et al.
Publicado: (2021)